Topical pritelivir: Ph II LipP1 started

AiCuris began the double-blind, U.S. Phase II LipP1 trial to compare 5% topical pritelivir applied to labial herpes 5 times daily for 4 days vs. Zovirax acyclovir cream or placebo in about 360 patient...